Prostate Cancer Biopsies

Video

E. David Crawford, MD, professor, Urologic and Radiation Oncology, head, Section of Urologic Oncology, University of Colorado at Denver, discusses prostate cancer biopsies.

E. David Crawford, MD, professor, Urologic and Radiation Oncology, head, Section of Urologic Oncology, University of Colorado at Denver, discusses prostate cancer biopsies.

Clinical Pearls:

  • Normally cancers are diagnosed through PET and CT scans but prostate cancer is diagnosed through biopsies
  • Instead of relying solely on results of transrectal biopsies, patients who are deemed low-risk are given mapping biopsies
  • Mapping biopsies allow physicians to keep an eye on cancer growth in order to determine if further treatment is needed
Related Videos
Video 5 - "Addressing Unmet Needs and Final Perspectives on nmCRPC"
Video 4 - "Integrating ARAMIS Trial Data and Managing Adverse Events in nmCRPC Treatment"
Video 3 - "Optimizing Treatment, Biomarkers, and Chemotherapy for Patients with nmCRPC"
Video 2 - "Addressing Risks and Challenges in the Standard of Care for Patients with nmCRPC"
Related Content